Company news

Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) news

Every Rain Enhancement Technologies Holdco, Inc. press release and news update in one place — announcements, filings coverage, and company updates for invest...

View Rain Enhancement Technologies Holdco, Inc. stock analysis →

Press releases & updates

Rainier Acquisition Corporation Announces Separation of Its Class A Ordinary Shares and Warrants on Nasdaq, Commencing September 14, 2026

September 11, 2026

Rain Enhancement Technologies to Present at H.C. Wainwright 28th Annual Global Investment Conference

September 9, 2026

Rainier Acquisition Corporation Announces Full Exercise of Over-Allotment Option, Bringing Total IPO Gross Proceeds to $86,250,000

September 2, 2026

Rain Enhancement Technologies Announces Agreement with California Highway Patrol to Test Fog Mitigation Technology

September 1, 2026

Rainier Acquisition Corporation Announces Closing of $75,000,000 Initial Public Offering

August 28, 2026

Rainier Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering

August 26, 2026

Rain Enhancement Technologies Recognized With 2026 "AgTech Climate Innovation of the Year" by AgTech Breakthrough

August 21, 2026

Rain Enhancement Technologies Reports Business Progress, Hosts Webcast Today

August 12, 2026

Rain Enhancement Technologies to Discuss Business Progress on Wednesday, August 12, 2026

August 5, 2026

Rain Enhancement Technologies to Present Four Precipitation Enhancement Studies at AMS Madison Summit

July 30, 2026

Rain Enhancement Technologies Announces Support for Colorado Weather Enhancement Paid Pilot Application, Target Install by October 2026

July 21, 2026

Rain Enhancement Technologies Reports WETA Delivers New Water at $10 Per Acre-Foot, a Fraction of the Cost of Conventional Supply Alterna...

June 9, 2026

Rain Enhancement Technologies Introduces Industry-First Guaranteed 10% Precipitation Enhancement

April 27, 2026

Rain City Resources Announces Revocation of Management Cease Trade Order

April 3, 2026

Rain Enhancement Technologies Reports Consistent Snowpack Enhancement Across Three-Month Winter Operations in Utah

March 31, 2026

Rain City Resources Provides Update on Management Cease Trade Order

March 26, 2026

Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations

February 12, 2026

Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations

February 12, 2026

Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation

February 5, 2026

Rain Enhancement Technologies Appoints David Sylvester, CFO of Steelcase, to Board of Directors

December 18, 2025

Rain Enhancement Technologies Reports Early Positive Indications From First Two U.S. Installations

December 16, 2025

Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities

November 18, 2025

Rain Enhancement Technologies Launches First U.S. Installation with Colorado Permit Approval

November 11, 2025

Rain Enhancement Technologies Holdco, Inc. Regains Compliance with Nasdaq Listing Requirements

November 7, 2025

Rain Enhancement Technologies Exhibits at Premier WMO Scientific Conference, Showcases Ionization Research Advancements

October 30, 2025

Rain Enhancement Technologies Reports Promising Results from Australia Fog Mitigation Pilot, Plans Expanded US Testing

October 28, 2025

Rain Enhancement Technologies Strengthens Strategic Leadership with Quantum Physics Pioneer and Corporate Governance Expert

October 15, 2025

Rain Enhancement Technologies Assembles World-Class Technical Advisory Board to Advance Weather Enhancement Innovation

September 18, 2025

RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. RECEIVES AND APPEALS NASDAQ DELISTING NOTICE

August 22, 2025

Rain Enhancement Technologies Announces Fog Mitigation Pilot in Australia

August 20, 2025

Rain Enhancement Technologies Strengthens Board of Directors with Appointment of Industry Veterans Bob Reardon and Marc Peperzak

August 12, 2025

Rain Enhancement Technologies Announces Appointment of Scott Morris as Senior Technical Advisor

August 7, 2025

Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer

February 3, 2025

Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 10, 2023

Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023

July 26, 2023

Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma

May 22, 2023

Rain Oncology Announces Collaborator Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023

April 5, 2023

Rain Oncology to Report Fourth Quarter and Full Year 2022 Financial Results and Highlights of Recent Progress on March 9, 2023

February 23, 2023

Rain Therapeutics Inc. Announces Name Change to Rain Oncology Inc.

December 29, 2022

Rain Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Progress

November 10, 2022

Rain Therapeutics Provides Interim Analysis of Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)

November 4, 2022

Rain Therapeutics Announces $50 Million Registered Offering of Common Stock

November 4, 2022

Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium

October 26, 2022

Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma

August 4, 2022

Rain Therapeutics Announces a Poster Presentation and Trials In Progress at the American Association for Cancer Research (AACR) Annual Me...

April 1, 2022

Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress

March 3, 2022

Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments

February 8, 2022

Rain Therapeutics Doses First Patient in Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)

November 19, 2021

Rain Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Progress

November 10, 2021

Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of Milademetan for De-differentiated Liposarcoma and Provides Patient Update fr...

July 20, 2021

Older →